
Cutaneous Manifestations of Mycobacterium kansasii Infection
Author(s) -
Leila Hojat,
F. Tobolowsky,
Carlos FrancoParedes
Publication year - 2018
Publication title -
current tropical medicine reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.333
H-Index - 18
ISSN - 2196-3045
DOI - 10.1007/s40475-018-0160-8
Subject(s) - mycobacterium kansasii , medicine , nontuberculous mycobacteria , immunology , skin infection , opportunistic infection , mycobacterium , disease , dermatology , pathology , tuberculosis , biology , human immunodeficiency virus (hiv) , viral disease , staphylococcus aureus , bacteria , genetics
Mycobacterium kansasii is a slow-growing member of the nontuberculous mycobacterial species that manifests clinically with pulmonary, cutaneous, or disseminated forms. Most cases of M. kansasii infection occur in immunocompromised hosts including HIV/AIDS, solid-organ transplantation, anti-interferon-γ antibody disorder, or among those with pulmonary disorders such as chronic obstructive pulmonary disease or cystic fibrosis. In this review, we aim to discuss relevant literature regarding the clinical manifestations of this infection with a particular emphasis on the clinical spectrum and treatment of the cutaneous manifestations of this mycobacterial infection.